Clinical Trial Update: Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome [Phase 3]

View source ↗

Summary

Reports the completion of a Phase 3 trial evaluating esomeprazole for gastric acid hypersecretory states, including Zollinger-Ellison syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Zollinger-ellison Syndrome

Drugs mentioned

• Esomeprazole (Esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Zollinger-Ellison Syndrome | Phase 3 | Status: COMPLETED